Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.22M | -60.78M | -63.42M | -58.21M | -60.66M |
| Total Depreciation and Amortization | 2.20M | 2.20M | 1.95M | 1.72M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.11M | 37.58M | 41.10M | 37.12M | 39.70M |
| Change in Net Operating Assets | 2.73M | -984.00K | -2.66M | -3.36M | -1.29M |
| Cash from Operations | -22.18M | -21.99M | -23.02M | -22.72M | -20.69M |
| Capital Expenditure | -3.19M | -1.92M | -957.00K | -799.00K | -516.00K |
| Sale of Property, Plant, and Equipment | -- | 4.00K | 4.00K | 4.00K | 4.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.19M | -1.92M | -953.00K | -795.00K | -512.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -690.00K | -414.00K | -380.00K | -299.00K | -201.00K |
| Issuance of Common Stock | 29.14M | 41.13M | 41.15M | 56.96M | 27.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 0.00 | 0.00 | -5.39M | -5.39M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -633.00K | -1.56M | -1.74M | -2.28M | -1.80M |
| Cash from Financing | 28.07M | 39.16M | 39.03M | 48.99M | 20.43M |
| Foreign Exchange rate Adjustments | -120.00K | -108.00K | -24.00K | -24.00K | -24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.58M | 15.15M | 15.03M | 25.45M | -796.00K |